Table 2.
Author | Year | Country | Ethnicity | Sex | Age (mean±SD) | Menopausal status | BMD instrument | Study design | No. of subjects | Polymorphism | BMD measurement | Covariates | Quality score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lorentzon et al. | 2000 | Sweden | European | Male | 16.9±0.3 | None | DPX-L | Population-based C | 90 | −174G/C | FN, LS, WB, Humerus | None | 6 |
Ferrari et al. | 2001 | USA | Mixeda | Female | 71.9±5.6 | Postmenopausal | QDR-4500 | Population-based C | 434 | −174G/C | FN, TH, TR, 1/3R, MID, UDR | Age | 7 |
Ota et al. | 2001 | Japan | Asian | Female | 73.2±5.8 | Postmenopausal | DPX-L | Population-based CS | 470 | −634C/G | Radial bone | Age, height, weight | 5 |
Fontova et al. | 2002 | Spain | European | Female | 59.0±4.7 | Postmenopausal | DPX-L | Hospital-based CC | 94 | −174G/C | FN, TR, WT, LS | None | 6 |
Garnero et al.-a | 2002 | France | European | Female | 40.0±6.2 | Premenopausal | QDR-2000 | Population-based C | 255 | −174G/C | FN, TH, TR, WT, LS, WB, DR, MID, UDR | None | 8 |
Garnero et al.-b | 2002 | France | European | Female | 64.0±8.6 | Postmenopausal | QDR-2000 | Population-based C | 372 | −174G/C | FN, TH, TR, LS, WB, DR, MID, UDR | None | 8 |
Chung et al. | 2003 | Korea | Asian | Female | 37.7±6.7 | Premenopausal | Lunar Pixi | Hospital-based CS | 331 | −634C/G | 1/3R | None | 7 |
Ferrari et al. | 2003 | USA | Mixeda | Female | 71.9±5.9 | Postmenopausal | QDR-4500 | Population-based C | 451 | −174G/C | LS | Age | 6 |
Yamada et al.-a | 2003 | Japan | Asian | Female | 46.2±5.0 | Premenopausal | DQR-4500, Desiscan 1000 | Population-based C | 279 | −634C/G | FN, TR, WT, LS, WB | Age, BMI | 8 |
Yamada et al.-b | 2003 | Japan | Asian | Female | 64.0±8.6 | Postmenopausal | DQR-4500, Desiscan 1000 | Population-based C | 817 | −634C/G | FN, TR, WT, LS, WB | Age, BMI | 8 |
Yamada et al.-c | 2003 | Japan | Asian | Male | 59.2±10.9 | None | DQR-4500, Desiscan 1000 | Population-based C | 1126 | −634C/G | FN, TR, WT, LS, WB | Age, BMI | 8 |
Ferrari et al.-a | 2004 | USA | Mixeda | Female | 59.5±9.2 | Mixedb | DPX-L | Population-based C | 816 | −174G/C, −634C/G |
FN, TR, WT | None | 8 |
Ferrari et al.-b | 2004 | USA | Mixeda | Male | 60.1±9.5 | None | DPX-L | Population-based C | 835 | −174G/C, −634C/G |
FN, TR, WT | None | 8 |
James et al.-a | 2004 | UK | European | Female | 60.7±0.0 | Postmenopausal | QDR-4500 | Population-based CRT | 35 | −174G/C | TH, WT, LS | None | 7 |
James et al.-b | 2004 | UK | European | Female | 60.7±0.0 | Postmenopausal | QDR-4500 | Population-based CRT | 30 | −174G/C | TH, WT, LS | None | 7 |
Moffett et al. | 2004 | USA | European | Female | 73.0±5.0 | Postmenopausal | QDR-1000 | Population-based C | 3376 | −174G/C | FN, TH, DR, PR | Age, BMI, estrogen use, study centerc | 8 |
Nordström et al. | 2004 | Sweden | European | Female | 75.0±0.0 | Postmenopausal | DPX-L | Population-based C | 964 | −174G/C | FN, LS, WB | None | 7 |
Li et al. | 2008 | China | Asian | Female | 10.0±0.7 | Premenarche | QDR-4500 | Population-based CS | 176 | −634C/G | FN, TH, LS, WB | None | 7 |
Czerny et al.-a | 2010 | Poland | European | Female | 63.3±5.1 | Postmenopausal | Lunar Densitometer | Hospital-based CC | 226 | −174G/C | FN, LS | None | 5 |
Czerny et al.-b | 2010 | Poland | European | Female | 64.8±6.3 | Postmenopausal | Lunar Densitometer | Hospital-based CC | 224 | −174G/C | FN, LS | None | 6 |
Deveci et al. | 2012 | Turkey | European | Female | 57.0±7.0 | Postmenopausal | NA | Hospital-based CC | 356 | −174G/C | TH, LS | None | 5 |
Oishi et al.-a | 2012 | Japan | Asian | Female | 19.3±1.0 | Premenopausal | Prodigy Advance | Population-based CS | 100 | −634C/G | FN, LS, WB | None | 4 |
Oishi et al.-b | 2012 | Japan | Asian | Female | 68.1±4.8 | Postmenopausal | QDR-A | Population-based CS | 100 | −634C/G | FN, LS, WB | Age, height, weight | 6 |
Mixed ethnicities, >94% Caucasians.
Eighty-five percent were postmenopausal women.
Unadjusted BMD was also available.
C, cohort; CS, cross-sectional study; CC, case–control study; CRT, cross-sectional on randomized control trial; FN, femoral neck; LS, lumbar spine; WB, whole body; TH, total hip; TR, trochanter; 1/3R, one-third distal radius; MID, mid-distal radius; UDR, ultradistal radius; WT, Ward's triangle; DR, distal radius; PR, proximal radius; NA, not available; SD, standard deviation; BMI, body mass index.